Deborah Lynch Email

Associate VP, Regulatory Affairs . ImClone

Current Roles

Employees:
473
Revenue:
$73.3M
About
ImClone Systems is a fully integrated global biopharmaceutical company committed to advancing oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. On November 24, 2008, ImClone Systems became a wholly-owned subsidiary of Eli Lilly and Company (NYSE: LLY).
ImClone Address

null, null
ImClone Email

Past Companies

HUTCHMED International CorporationExecutive Director
Merck & CoSenior Director - Global Regulatory Affairs Lead - Oncology
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and CompanyAssociate Vice President, Regulatory Affairs

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.